Alex Therapeutics is a digital therapeutics (DTx) company based in Stockholm which designs and develops Software-as-a-Medical-Devices. With the proven “Alex DTx Platform”, expertise in artificial intelligence and evidence-based psychology, Alex Therapeutics is uniquely positioned to deliver cutting-edge and reliable DTx products. Alex Therapeutics has strategic commercial partnerships with global pharmaceutical companies, including Pfizer. The initial focus of the Pfizer partnership is Alex Therapeutics’ DTx product Eila® to treat nicotine addiction
![Alex Therapeutics Color (1)](https://hadeanventures.com/wp-content/uploads/2022/04/Alex-Therapeutics-Color-1-1-300x86.png)
Year of investment
2022
Sector
Digital Health (DTx)
Location
Stockholm, Sweden
Website
http://alextherapeutics.com/